Literature DB >> 18946713

Relapsing polychondritis--case series from South India.

Rajiv Ananthakrishna1, Ruchika Goel, Prasanta Padhan, John Mathew, Debashish Danda.   

Abstract

Relapsing polychondritis (RP) is a rare recurring inflammatory disorder with variable clinical course. It has been described mainly in Caucasian population. Reports from other ethnic groups are few. We report seven cases of relapsing polychondritis in south Indian population. In between 1995 and 2008, seven patients fulfilling the McAdam-Damiani-Levine criteria for diagnosis of relapsing polychondritis were identified. Records pertaining to these patients were studied and clinical presentation, course, and treatment offered were analyzed retrospectively. The female-to-male ratio in our series was 2.5:1. The age of onset of symptoms ranged from 28 to 54 years, with a mean of 40.2 years. An average of 20 months, ranging from 3 months to 6 years, elapsed before the patient presented to us seeking a diagnosis. Various structural involvement in our series were as follows: pinna in four (57%), nasal cartilage in five (71%), joints in three (43%), eyes in three (43%), laryngotracheal tree in three (43%), inner ear in one (14.3%), skin in one (14.3%), and heart in one (14.3%). Associated autoimmune diseases were present in four (57%) patients in the form of one of the following in each: vasculitis, autoimmune hemolytic anemia, hypothyroidism, and rheumatoid arthritis. All seven patients received prednisolone with three of them requiring additional immunosuppressants. There was no mortality amongst the four patients who had remained on follow-up at the time of this report. Although RP is an uncommon disorder, clinicians should be aware of the manifestations so as to initiate prompt treatment and prevent complications. Our series reports less frequent auricular cartilage and skin involvement and an exceptional case of basal cell carcinoma, although the other manifestations were similar to that seen in Caucasian and other Asian populations.

Entities:  

Mesh:

Year:  2008        PMID: 18946713     DOI: 10.1007/s10067-008-1016-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  12 in total

Review 1.  Relapsing polychondritis: a clinical review.

Authors:  Erik Letko; Panayotis Zafirakis; Stefanos Baltatzis; Adamantia Voudouri; Charalampos Livir-Rallatos; C Stephen Foster
Journal:  Semin Arthritis Rheum       Date:  2002-06       Impact factor: 5.532

Review 2.  Relapsing polychondritis.

Authors:  Peter Gergely; Gyula Poór
Journal:  Best Pract Res Clin Rheumatol       Date:  2004-10       Impact factor: 4.098

Review 3.  Relapsing polychondritis.

Authors:  D E Trentham; C H Le
Journal:  Ann Intern Med       Date:  1998-07-15       Impact factor: 25.391

4.  Relapsing polychondritis: clinical and immunogenetic analysis of 62 patients.

Authors:  M Zeuner; R H Straub; G Rauh; E D Albert; J Schölmerich; B Lang
Journal:  J Rheumatol       Date:  1997-01       Impact factor: 4.666

5.  Relapsing polychondritis. Analytical literature review and studies on pathogenesis.

Authors:  D L Dolan; G B Lemmon; S L Teitelbaum
Journal:  Am J Med       Date:  1966-08       Impact factor: 4.965

Review 6.  Relapsing polychondritis: prospective study of 23 patients and a review of the literature.

Authors:  L P McAdam; M A O'Hanlan; R Bluestone; C M Pearson
Journal:  Medicine (Baltimore)       Date:  1976-05       Impact factor: 1.889

7.  Relapsing polychondritis in North India: a report of 10 patients.

Authors:  A Sharma; P Bambery; A Wanchu; Y P Sharma; N K Panda; A Gupta; S Singh
Journal:  Scand J Rheumatol       Date:  2007 Nov-Dec       Impact factor: 3.641

8.  Prevalence of head and neck cancers in the north east-An institutional study.

Authors:  Abhinandan Bhattacharjee; A Chakraborty; P Purkaystha
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2006-01

9.  Antibodies to type II collagen in relapsing polychondritis.

Authors:  J M Foidart; S Abe; G R Martin; T M Zizic; E V Barnett; T J Lawley; S I Katz
Journal:  N Engl J Med       Date:  1978-11-30       Impact factor: 91.245

Review 10.  Relapsing polychondritis.

Authors:  J W White
Journal:  South Med J       Date:  1985-04       Impact factor: 0.954

View more
  7 in total

Review 1.  Aortic involvement in relapsing polychondritis: case-based review.

Authors:  Mustafa Erdogan; Sinem Nihal Esatoglu; Gulen Hatemi; Vedat Hamuryudan
Journal:  Rheumatol Int       Date:  2019-11-25       Impact factor: 2.631

Review 2.  Relapsing polychondritis: a review.

Authors:  Aman Sharma; Karthik Gnanapandithan; Kusum Sharma; Susmita Sharma
Journal:  Clin Rheumatol       Date:  2013-07-26       Impact factor: 2.980

Review 3.  Clinical and prognostic characteristics of 158 cases of relapsing polychondritis in China and review of the literature.

Authors:  Dong-Fang Lin; Wei-Qiang Yang; Ping-Ping Zhang; Qing Lv; Ou Jin; Jie-Ruo Gu
Journal:  Rheumatol Int       Date:  2016-03-07       Impact factor: 2.631

4.  FDG PET-CT combined with TBNA for the diagnosis of atypical relapsing polychondritis: report of 2 cases and a literature review.

Authors:  Wei Lei; Da-Xiong Zeng; Tao Chen; Jun-Hong Jiang; Chang-Guo Wang; Ye-Han Zhu; Jian-An Huang
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

5.  Comparison of relapsing polychondritis patients with and without respiratory involvement based on chest computed tomography: a retrospective cohort study.

Authors:  Dong Wang; Lujia Guan; Xin Dong; Xiaofan Zhu; Zhaohui Tong
Journal:  BMC Pulm Med       Date:  2022-06-08       Impact factor: 3.320

6.  Relapsing polychondritis: clinical presentations, disease activity and outcomes.

Authors:  Aman Sharma; Arjun Dutt Law; Pradeep Bambery; Vinay Sagar; Ajay Wanchu; Varun Dhir; Rajesh Vijayvergiya; Kusum Sharma; Ashok Gupta; Naresh K Panda; Surjit Singh
Journal:  Orphanet J Rare Dis       Date:  2014-12-20       Impact factor: 4.123

7.  Case report of mixed-type autoimmune hemolytic anemia in a patient with relapsing polychondritis.

Authors:  Qianyun Xu; Hui Luo; Xiaoxia Zuo; Sijia Liu
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.